Evaluation of Biomarkers of Oxidative Stress and Apoptosis in Patients With Severe Methotrexate Neurotoxicity: A Case Series

Olga A. Taylor, Marilyn J. Hockenberry, Kathy McCarthy, Patricia Gundy, David W Montgomery, Adam Ross, Michael E. Scheurer, Ida M Moore

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Central nervous system (CNS) treatment is an essential part of acute lymphocytic leukemia (ALL) therapy, and the most common CNS treatment is intrathecal (IT) and high-dose intravenous (IV) methotrexate (MTX). Treatment with MTX may cause neurotoxicity, which is often accompanied by neurologic changes, delays in treatment, and prolonged hospital stays. This article reports clinical presentations of 3 patients with severe MTX toxicity as well as levels of oxidative stress and apoptosis biomarkers in cerebrospinal fluid (CSF). Oxidative stress was measured by oxidized phosphatidylcholine (PC), oxidized phosphatidylinositol (PI), and F2 isoprostanes; apoptosis was measured by caspase 3/7 activity. Most consistent biomarker changes in all 3 cases were increases in caspase 3/7 and F2 isoprostanes prior to acute toxicity while increases in oxidized phospholipids occurred slightly later. Progressive increases in F2 isoprostanes and caspase 3/7 activity prior to and/or during acute toxicity suggests MTX induces oxidative stress and an associated increase in apoptosis. These findings support the role of oxidative stress in MTX-related neurotoxicity.

Original languageEnglish (US)
Pages (from-to)320-325
Number of pages6
JournalJournal of Pediatric Oncology Nursing
Volume32
Issue number5
DOIs
StatePublished - Sep 12 2015

Fingerprint

Methotrexate
F2-Isoprostanes
Oxidative Stress
Caspase 7
Biomarkers
Apoptosis
Caspase 3
Central Nervous System
Therapeutics
Phosphatidylinositols
Phosphatidylcholines
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Nervous System
Cerebrospinal Fluid
Length of Stay
Phospholipids

Keywords

  • leukemia
  • methotrexate
  • neurotoxicity
  • oxidative stress

ASJC Scopus subject areas

  • Oncology(nursing)
  • Pediatrics

Cite this

Evaluation of Biomarkers of Oxidative Stress and Apoptosis in Patients With Severe Methotrexate Neurotoxicity : A Case Series. / Taylor, Olga A.; Hockenberry, Marilyn J.; McCarthy, Kathy; Gundy, Patricia; Montgomery, David W; Ross, Adam; Scheurer, Michael E.; Moore, Ida M.

In: Journal of Pediatric Oncology Nursing, Vol. 32, No. 5, 12.09.2015, p. 320-325.

Research output: Contribution to journalArticle

Taylor, Olga A. ; Hockenberry, Marilyn J. ; McCarthy, Kathy ; Gundy, Patricia ; Montgomery, David W ; Ross, Adam ; Scheurer, Michael E. ; Moore, Ida M. / Evaluation of Biomarkers of Oxidative Stress and Apoptosis in Patients With Severe Methotrexate Neurotoxicity : A Case Series. In: Journal of Pediatric Oncology Nursing. 2015 ; Vol. 32, No. 5. pp. 320-325.
@article{ac689bb9006b4de991158d28a9e75018,
title = "Evaluation of Biomarkers of Oxidative Stress and Apoptosis in Patients With Severe Methotrexate Neurotoxicity: A Case Series",
abstract = "Central nervous system (CNS) treatment is an essential part of acute lymphocytic leukemia (ALL) therapy, and the most common CNS treatment is intrathecal (IT) and high-dose intravenous (IV) methotrexate (MTX). Treatment with MTX may cause neurotoxicity, which is often accompanied by neurologic changes, delays in treatment, and prolonged hospital stays. This article reports clinical presentations of 3 patients with severe MTX toxicity as well as levels of oxidative stress and apoptosis biomarkers in cerebrospinal fluid (CSF). Oxidative stress was measured by oxidized phosphatidylcholine (PC), oxidized phosphatidylinositol (PI), and F2 isoprostanes; apoptosis was measured by caspase 3/7 activity. Most consistent biomarker changes in all 3 cases were increases in caspase 3/7 and F2 isoprostanes prior to acute toxicity while increases in oxidized phospholipids occurred slightly later. Progressive increases in F2 isoprostanes and caspase 3/7 activity prior to and/or during acute toxicity suggests MTX induces oxidative stress and an associated increase in apoptosis. These findings support the role of oxidative stress in MTX-related neurotoxicity.",
keywords = "leukemia, methotrexate, neurotoxicity, oxidative stress",
author = "Taylor, {Olga A.} and Hockenberry, {Marilyn J.} and Kathy McCarthy and Patricia Gundy and Montgomery, {David W} and Adam Ross and Scheurer, {Michael E.} and Moore, {Ida M}",
year = "2015",
month = "9",
day = "12",
doi = "10.1177/1043454214563409",
language = "English (US)",
volume = "32",
pages = "320--325",
journal = "Journal of Pediatric Oncology Nursing",
issn = "1043-4542",
publisher = "SAGE Publications Inc.",
number = "5",

}

TY - JOUR

T1 - Evaluation of Biomarkers of Oxidative Stress and Apoptosis in Patients With Severe Methotrexate Neurotoxicity

T2 - A Case Series

AU - Taylor, Olga A.

AU - Hockenberry, Marilyn J.

AU - McCarthy, Kathy

AU - Gundy, Patricia

AU - Montgomery, David W

AU - Ross, Adam

AU - Scheurer, Michael E.

AU - Moore, Ida M

PY - 2015/9/12

Y1 - 2015/9/12

N2 - Central nervous system (CNS) treatment is an essential part of acute lymphocytic leukemia (ALL) therapy, and the most common CNS treatment is intrathecal (IT) and high-dose intravenous (IV) methotrexate (MTX). Treatment with MTX may cause neurotoxicity, which is often accompanied by neurologic changes, delays in treatment, and prolonged hospital stays. This article reports clinical presentations of 3 patients with severe MTX toxicity as well as levels of oxidative stress and apoptosis biomarkers in cerebrospinal fluid (CSF). Oxidative stress was measured by oxidized phosphatidylcholine (PC), oxidized phosphatidylinositol (PI), and F2 isoprostanes; apoptosis was measured by caspase 3/7 activity. Most consistent biomarker changes in all 3 cases were increases in caspase 3/7 and F2 isoprostanes prior to acute toxicity while increases in oxidized phospholipids occurred slightly later. Progressive increases in F2 isoprostanes and caspase 3/7 activity prior to and/or during acute toxicity suggests MTX induces oxidative stress and an associated increase in apoptosis. These findings support the role of oxidative stress in MTX-related neurotoxicity.

AB - Central nervous system (CNS) treatment is an essential part of acute lymphocytic leukemia (ALL) therapy, and the most common CNS treatment is intrathecal (IT) and high-dose intravenous (IV) methotrexate (MTX). Treatment with MTX may cause neurotoxicity, which is often accompanied by neurologic changes, delays in treatment, and prolonged hospital stays. This article reports clinical presentations of 3 patients with severe MTX toxicity as well as levels of oxidative stress and apoptosis biomarkers in cerebrospinal fluid (CSF). Oxidative stress was measured by oxidized phosphatidylcholine (PC), oxidized phosphatidylinositol (PI), and F2 isoprostanes; apoptosis was measured by caspase 3/7 activity. Most consistent biomarker changes in all 3 cases were increases in caspase 3/7 and F2 isoprostanes prior to acute toxicity while increases in oxidized phospholipids occurred slightly later. Progressive increases in F2 isoprostanes and caspase 3/7 activity prior to and/or during acute toxicity suggests MTX induces oxidative stress and an associated increase in apoptosis. These findings support the role of oxidative stress in MTX-related neurotoxicity.

KW - leukemia

KW - methotrexate

KW - neurotoxicity

KW - oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=84938847184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938847184&partnerID=8YFLogxK

U2 - 10.1177/1043454214563409

DO - 10.1177/1043454214563409

M3 - Article

C2 - 25637187

AN - SCOPUS:84938847184

VL - 32

SP - 320

EP - 325

JO - Journal of Pediatric Oncology Nursing

JF - Journal of Pediatric Oncology Nursing

SN - 1043-4542

IS - 5

ER -